Bank of America’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bank of America’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,100	Closed	-$1.11M	–	8149
2023 Q2	$1.11M	Sell	28,100 -171,100	-86%	-$6.04M	﹤0.01%	4707
2023 Q1	$4.85M	Buy	+199,200	New	+$4.36M	﹤0.01%	3569
2017 Q1	–	Sell	-40,700	Closed	-$197K	–	7320
2016 Q4	$197K	Hold	40,700	–	–	﹤0.01%	5333
2016 Q3	$1.88M	Buy	+40,700	New	+$2.3M	﹤0.01%	3686
2015 Q2	–	Sell	-50,000	Closed	-$2.33M	–	7468
2015 Q1	$2.33M	Buy	+50,000	New	+$2.6M	﹤0.01%	3106

Bank of America's ISEE Position: Q3 2023 in Review

Bank of America sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,637,560 shares — an estimated $64.4M sold.

Bank of America first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $64.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Bank of America reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of America sold 1,637,560 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $64.4M.
Bank of America first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
Bank of America's IVERIC bio, Inc. Common Stock position peaked at $64.4M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.